Skip to main content

Abdominal Aortic Aneurysms in Patients with Diabetes

  • Chapter
  • First Online:
Diabetes and Peripheral Vascular Disease

Part of the book series: Contemporary Diabetes ((CDI))

  • 2328 Accesses

Abstract

Patients with abdominal aortic aneurysms (AAAs) share many of the traditional risk factors for atherosclerosis with the notable exception of diabetes, as diabetes is paradoxically protective against AAA formation. Furthermore, if diabetics develop AAAs, they have a slower rate of AAA progression. Speculation as to the mechanism(s) involved in these protective features is multifactorial, including (1) a thicker aortic wall in diabetics as compared to non-diabetics; (2) decreased levels of matrix metalloproteinases (MMPs), especially MMP2 and 9, in the diabetic aorta with relative preservation of elastin fibers in the medial layer; and (3) increased plasminogen activator inhibitor-1 activity in diabetics. However, once AAA repair is indicated, diabetes is no longer protective, and the surgical team must consider complications associated with diabetes. Comorbidities that have the greatest impact on AAA repair include cardiac dysfunction, renal impairment, and complications associated with increased atherosclerotic disease. AAAs may be repaired either endovascularly or open with efforts made to preserve renal function. While diabetes alone is not associated with poor postoperative outcomes, comorbid conditions associated with diabetes, such as renal failure, are linked with increased mortality. Blood glucose concentrations must be carefully controlled perioperatively to decrease wound complications. Nephrotoxic agents, especially iodinated contrast, should be avoided if possible, and alternative methods of surveillance may include ultrasound and noncontrast computed tomography. While diabetes is protective from developing AAAs, clinicians caring for patients with diabetes who undergo AAA repair should be aware of the increased risk of perioperative complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lederle FA, Johnson GR, Wilson SE, et al. Relationship of age, gender, race, and body size to infrarenal aortic diameter. J Vasc Surg. 1997;26:595–601.

    Article  PubMed  CAS  Google Scholar 

  2. Lederle FA, Johnson GR, Wilson SE, et al. The aneurysm detection and management study screening program: validation cohort and final results. Arch Intern Med. 2000;160:1425–30.

    Article  PubMed  CAS  Google Scholar 

  3. Norman PE, Jamrozik K, Lawrence-Brown MM, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329:1259.

    Article  PubMed  Google Scholar 

  4. Scott RAP, Bridgewater SG, Ashton HA. Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 2002;89:283–5.

    Article  PubMed  CAS  Google Scholar 

  5. Lederle FA, Johnson GR, Wilson SE. Abdominal aortic aneurysm in women. J Vasc Surg. 2001;34:122–6.

    Article  PubMed  CAS  Google Scholar 

  6. Lederle FA, Larson JC, Margolis KL, et al. Abdominal aortic aneurysm events in the women’s health initiative: cohort study. BMJ. 2008;337:a1724.

    Article  PubMed  Google Scholar 

  7. Guirguis EM, Barber GG. The natural history of abdominal aortic aneurysms. Am J Surg. 1991;162:481–3.

    Article  PubMed  CAS  Google Scholar 

  8. Bown MJ, Sutton AJ, Bell PRF, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg. 2002;89:714–30.

    Article  PubMed  CAS  Google Scholar 

  9. Semmens JB, Norman PE, Lawrence-Brown MMD, Holman CDAJ. Influence of gender on outcome from ruptured abdominal aortic aneurysm. Br J Surg. 2000;87:191–4.

    Article  PubMed  CAS  Google Scholar 

  10. Powell JT. Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg. 2007;94:702–8.

    Article  PubMed  CAS  Google Scholar 

  11. Brown PM, Zelt DT, Sobolev B. The risk of rupture in untreated aneurysms: the impact of size, gender, and expansion rate. J Vasc Surg. 2003;37:280–4.

    Article  PubMed  Google Scholar 

  12. Pleumeekers HJ, Hoes AW, van der Does E, et al. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol. 1995;142:1291–9.

    PubMed  CAS  Google Scholar 

  13. Alcorn HG, Wolfson Jr SK, Sutton-Tyrrell K, Kuller LH, O’Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in the cardiovascular health study. Arterioscler Thromb Vasc Biol. 1996;16:963–70.

    Article  PubMed  CAS  Google Scholar 

  14. Singh K, B∅naa KH, Jacobsen BK, Bj∅rk L, Solberg S. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study. Am J Epidemiol. 2001;154:236–44.

    Article  PubMed  CAS  Google Scholar 

  15. Lee AJ, Fowkes FGR, Carson MN, Leng GC, Allan PL. Smoking, atherosclerosis and risk of abdominal aortic aneurysm. Eur Heart J. 1997;18:671–6.

    Article  PubMed  CAS  Google Scholar 

  16. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg. 2001;33:91–6.

    Article  PubMed  CAS  Google Scholar 

  17. Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol. 2000;151:575–83.

    Article  PubMed  CAS  Google Scholar 

  18. Le MT, Jamrozik K, Davis TM, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg. 2007;33:599–604.

    Article  PubMed  CAS  Google Scholar 

  19. Miyama N, Dua MM, Yeung JJ, et al. Hyperglycemia limits experimental aortic aneurysm progression. J Vasc Surg. 2010;52:975–83.

    Article  PubMed  Google Scholar 

  20. Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16–21.

    Article  PubMed  Google Scholar 

  21. Golledge J, Karan M, Moran CS, et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008;29:665–72.

    Article  PubMed  CAS  Google Scholar 

  22. Fillinger MF, Marra SP, Raghavan ML, Kennedy FE. Prediction of rupture risk in abdominal aortic aneurysm during observation: wall stress versus diameter. J Vasc Surg. 2003;37:724–32.

    Article  PubMed  Google Scholar 

  23. Astrand H, Ryden-Ahlgren A, Sundkvist G, Sandgren T, Lanne T. Reduced aortic wall stress in diabetes mellitus. Eur J Vasc Endovasc Surg. 2007;33:592–8.

    Article  PubMed  CAS  Google Scholar 

  24. Giannattasio C, Failla M, Piperno A, et al. Early impairment of large artery structure and function in Type I diabetes mellitus. Diabetologia. 1999;42:987–94.

    Article  PubMed  CAS  Google Scholar 

  25. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–4.

    Article  PubMed  CAS  Google Scholar 

  26. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996;800:157–74.

    Article  PubMed  CAS  Google Scholar 

  27. Eagleton MJ, Ballard N, Lynch E, Srivastava SD, Upchurch Jr GR, Stanley JC. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during angiotensin II induced aneurysm formation. J Surg Res. 2006;135:345–51.

    Article  PubMed  CAS  Google Scholar 

  28. Ailawadi G, Eliason JL, Roelofs KJ, et al. Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2004;24:2116–22.

    Article  PubMed  CAS  Google Scholar 

  29. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circ Res. 2003;92:827–39.

    Article  PubMed  CAS  Google Scholar 

  30. Davis V, Persidskaia R, Baca-Regen L, et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 1998;18:1625–33.

    Article  PubMed  CAS  Google Scholar 

  31. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318–26.

    Article  PubMed  CAS  Google Scholar 

  32. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15:1145–51.

    Article  PubMed  CAS  Google Scholar 

  33. Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes. 2002;51:3063–8.

    Article  PubMed  CAS  Google Scholar 

  34. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625–32.

    PubMed  CAS  Google Scholar 

  35. Dua MM, Miyama N, Azuma J, et al. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery. 2010;148:429–35.

    Article  PubMed  Google Scholar 

  36. Louwrens HD, Kwaan HC, Pearce WH, Yao JST, Verrusio E. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. Eur J Vasc Endovasc Surg. 1995;10:289–93.

    Article  PubMed  CAS  Google Scholar 

  37. DiMusto PD, Lu G, Ghosh A, Roelofs KJ, Su G, Zhao Y, Lau CL, Sadiq O, McEvoy B, Laser A, Diaz JA, Wakefield TW, Henke PK, Eliason JL, Upchurch GR, Jr. Increased pai-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol. 2012;302:H1378–86.

    Article  PubMed  CAS  Google Scholar 

  38. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532–9.

    Article  PubMed  Google Scholar 

  39. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23:962–8.

    Article  PubMed  CAS  Google Scholar 

  40. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110:859–66.

    PubMed  CAS  Google Scholar 

  41. Back MR, Schmacht DC, Bowser AN, et al. Critical appraisal of cardiac risk stratification before elective vascular surgery. Vasc Endovascular Surg. 2003;37:387–97.

    Article  PubMed  Google Scholar 

  42. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.

    Article  PubMed  Google Scholar 

  43. Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2004;28:343–52.

    Article  PubMed  CAS  Google Scholar 

  44. USRDS. 2011 USRDS Annual Date Report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: US Renal Data System; 2011.

    Google Scholar 

  45. Shteinberg D, Halak M, Shapiro S, et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg. 2000;20:462–5.

    Article  PubMed  CAS  Google Scholar 

  46. LaMorte WW, Scott TE, Menzoian JO. Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors. J Vasc Surg. 1995;21:422–31.

    Article  PubMed  CAS  Google Scholar 

  47. Hooi JD, Stoffers HE, Kester AD, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998;16:177–82.

    Article  PubMed  CAS  Google Scholar 

  48. Hua HT, Cambria RP, Chuang SK, et al. Early outcomes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality Improvement Program-Private Sector (NSQIP-PS). J Vasc Surg. 2005;41:382–9.

    Article  PubMed  Google Scholar 

  49. Welten GMJM, Chonchol M, Schouten O, et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008;23:3867–73.

    Article  PubMed  CAS  Google Scholar 

  50. Dardik A, Lin JW, Gordon TA, Williams GM, Perler BA. Results of elective abdominal aortic aneurysm repair in the 1990s: a population-based analysis of 2335 cases. J Vasc Surg. 1999;30:985–95.

    Article  PubMed  CAS  Google Scholar 

  51. Axelrod DA, Upchurch Jr GR, DeMonner S, et al. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. J Vasc Surg. 2002;35:894–901.

    Article  PubMed  Google Scholar 

  52. Lederle FA, Freischlag JA, Kyriakides TC, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA. 2009;302:1535–42.

    Article  PubMed  CAS  Google Scholar 

  53. Nathan DP, Brinster CJ, Jackson BM, et al. Predictors of decreased short- and long-term survival following open abdominal aortic aneurysm repair. J Vasc Surg. 2011;54:1237–43.

    Article  PubMed  Google Scholar 

  54. Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249:851–8.

    Article  PubMed  Google Scholar 

  55. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848–51.

    Article  PubMed  CAS  Google Scholar 

  56. Yeung KK, Jongkind V, Coveliers HME, Tangelder GJ, Wisselink W. Routine continuous cold perfusion of the kidneys during elective juxtarenal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2008;35:446–51.

    Article  PubMed  CAS  Google Scholar 

  57. Nathan DP, Brinster CJ, Woo EY, Carpenter JP, Fairman RM, Jackson BM. Predictors of early and late mortality following open extent IV thoracoabdominal aortic aneurysm repair in a large contemporary single-center experience. J Vasc Surg. 2011;53:299–306.

    Article  PubMed  Google Scholar 

  58. Mehta M, Cayne N, Veith FJ, et al. Relationship of proximal fixation to renal dysfunction in patients undergoing endovascular aneurysm repair. J Cardiovasc Surg (Torino). 2004;45:367–74.

    CAS  Google Scholar 

  59. Lau LL, Hakaim AG, Oldenburg WA, et al. Effect of suprarenal versus infrarenal aortic endograft fixation on renal function and renal artery patency: a comparative study with intermediate follow-up. J Vasc Surg. 2003;37:1162–8.

    Article  PubMed  Google Scholar 

  60. Tambyraja AL, Fishwick NG, Bown MJ, Nasim A, McCarthy MJ, Sayers RD. Fenestrated aortic endografts for juxtarenal aortic aneurysm: medium term outcomes. Eur J Vasc Endovasc Surg. 2011;42:54–8.

    Article  PubMed  CAS  Google Scholar 

  61. Hiramoto JS, Chang CK, Reilly LM, Schneider DB, Rapp JH, Chuter TA. Outcome of renal stenting for renal artery coverage during endovascular aortic aneurysm repair. J Vasc Surg. 2009;49:1100–6.

    Article  PubMed  Google Scholar 

  62. Haddad F, Greenberg RK, Walker E, et al. Fenestrated endovascular grafting: the renal side of the story. J Vasc Surg. 2005;41:181–90.

    Article  PubMed  Google Scholar 

  63. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol. 2001;12:3–9.

    Article  PubMed  CAS  Google Scholar 

  64. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–9.

    Article  PubMed  CAS  Google Scholar 

  65. Hawkins IF, Cho KJ, Caridi JG. Carbon dioxide in angiography to reduce the risk of contrast-induced nephropathy. Radiol Clin North Am. 2009;47:813–25, v–vi.

    Google Scholar 

  66. Chao A, Major K, Kumar SR, et al. Carbon dioxide digital subtraction angiography-assisted endovascular aortic aneurysm repair in the azotemic patient. J Vasc Surg. 2007;45:451–8.

    Article  PubMed  Google Scholar 

  67. Knipp BS, Escobar GA, English S, Upchurch Jr GR, Criado E. Endovascular repair of ruptured aortic aneurysms using carbon dioxide contrast angiography. Ann Vasc Surg. 2010;24:845–50.

    Article  PubMed  Google Scholar 

  68. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284–94.

    PubMed  Google Scholar 

  69. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol. 2008;3:10–8.

    Article  PubMed  CAS  Google Scholar 

  70. Baker CSR, Wragg A, Kumar S, De Palma R, Baker LRI, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003;41:2114–8.

    Article  PubMed  Google Scholar 

  71. Nagre SB, Taylor SM, Passman MA, et al. Evaluating outcomes of endoleak discrepancies between computed tomography scan and ultrasound imaging after endovascular abdominal aneurysm repair. Ann Vasc Surg. 2011;25:94–100.

    Article  PubMed  Google Scholar 

  72. Schmieder GC, Stout CL, Stokes GK, Parent FN, Panneton JM. Endoleak after endovascular aneurysm repair: duplex ultrasound imaging is better than computed tomography at determining the need for intervention. J Vasc Surg. 2009;50:1012–7. Discussion 7–8.

    Article  PubMed  Google Scholar 

  73. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219–22.

    Article  PubMed  CAS  Google Scholar 

  74. Sorensen LT, Hemmingsen U, Kallehave F, et al. Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg. 2005;241:654–8.

    Article  PubMed  Google Scholar 

  75. Richet HM, Chidiac C, Prat A, et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med. 1991;91:S170–2.

    Article  Google Scholar 

  76. Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145:858–64.

    Article  PubMed  Google Scholar 

  77. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50:e159–242.

    Article  PubMed  Google Scholar 

  78. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.

    Article  PubMed  CAS  Google Scholar 

  79. Brewster DC, Cronenwett JL, Hallett Jr JW, Johnston KW, Krupski WC, Matsumara JS. Guidlines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg. 2003;37:1106–17.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilbert R. Upchurch Jr. M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Johnston, W.F., Upchurch, G.R. (2012). Abdominal Aortic Aneurysms in Patients with Diabetes. In: Shrikhande, G., McKinsey, J. (eds) Diabetes and Peripheral Vascular Disease. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-158-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-158-5_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-157-8

  • Online ISBN: 978-1-62703-158-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics